本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

25.13
+1.626.89%
成交量:243.86萬
成交額:6,090.60萬
市值:31.43億
市盈率:116.66
高:25.62
開:23.63
低:23.63
收:23.51
52周最高:31.77
52周最低:16.57
股本:1.25億
流通股本:1.11億
量比:1.56
換手率:2.19%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
淨資產收益率:15.86%
總資產收益率:5.09%
市淨率:14.25
市盈率(LYR):-198.09

資料載入中...

2024/07/25

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/10

重要事件披露

Form 8-K - Current report
2024/03/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities